Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/18/10 18:50 | 10/15/10 | ABII | Health | Drug | Pharmaceutical Preparations | Celgene Corp /de/ | NJ | T | P | 0 | 0.00 | 0 | 40,735 | 0 | D | ||||||||||||||||
2/26/10 16:38 | 2/24/10 | ABII | Health | Drug | Pharmaceutical Preparations | Soon Shiong Patrick | CA | DOT | Exec CB | M.d | 1,311 | 7.92 | 0 | 165 | 1 | 33,192 | D | ||||||||||||||
11/12/09 17:54 | 11/10/09 | ABII | Health | Drug | Pharmaceutical Preparations | Wendel Bruce | CA | O | EVP Corp | S | -28 | 35.42 | 0 | -1 | -42 | 1 | D | ||||||||||||||
3/3/09 21:50 | 3/2/09 | ABII | Health | Drug | Pharmaceutical Preparations | Soon Shiong Patrick | CA | DOT | CB,CEO | M.d | 0 | 0.00 | 0 | 2 | 6 | 38 | |||||||||||||||
3/3/09 21:48 | 3/2/09 | ABII | Health | Drug | Pharmaceutical Preparations | Geehr Ed | CA | O | EVP Oper | M.d | 0 | 0.00 | 0 | 1 | 1 | ||||||||||||||||
3/3/09 21:46 | 3/2/09 | ABII | Health | Drug | Pharmaceutical Preparations | Wendel Bruce | CA | O | EVP Corp | M.d | 0 | 0.00 | 0 | 1 | 4 | 23 | |||||||||||||||
3/3/09 21:44 | 3/2/09 | ABII | Health | Drug | Pharmaceutical Preparations | O'Toole David D. | CA | O | CFO,EVP | M.d | 0 | 0.00 | 0 | 1 | 110 | 2 | |||||||||||||||
6/10/08 20:00 | 6/6/08 | ABII | Health | Drug | Pharmaceutical Preparations | Chen David | CA | D | S | -124 | 66.39 | 0 | -2 | -4 | 47 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |